EQUITY-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of assumptions to estimate the grant date fair value of stock options and SARs
  Years Ended December 31, 
  2016  2015  2014 
Volatility  42.4%  43.0%  57.8%
Expected term (in years)  5.4   5.5   6.2 
Risk-free rate  1.40%  1.65%  1.88%
Dividend yield  0%  0%  0%
Schedule of summary of stock option and SAR activity outstanding
     Weighted 
     Average 
  Shares  Exercise Price 
Outstanding, January 1, 2016  1,529  $8.69 
Granted  966   7.11 
Exercised  (238)  4.32 
Forfeited or expired  (608)  9.77 
Outstanding, at December 31, 2016  1,649   7.97 
Exercisable at December 31, 2016  453   9.04 
Schedule of summary of stock option and SAR
  Outstanding  Exercisable 
Total shares  1,649  453 
Aggregate intrinsic value $562 $562 
Weighted-average remaining contractual term (years)  7.9  4.6 
Schedule of summary of stock option and SAR exercise data
  Years Ended December 31, 
  2016  2015  2014 
Options and SARs exercised  238   56   270 
Net shares issued  158   51   214 
Total intrinsic value exercised $559  $195  $1,533 
Cash received $537  $254  $931 
Recognized tax benefit $559  $96  $1,300 
Schedule of summary of non-vested share restricted stock award activity
  Shares  Weighted
Average Grant
Date Fair Value		 
Outstanding, as of January 1, 2016  538  $9.59 
Granted  432   7.14 
Vested  (168)  9.12 
Forfeited  (139)  9.70 
Outstanding, as of December 31, 2016  663   8.08